JAMA, The Journal of the American Medical Association 2004 Michael A. Blazing - Abstracts
| JAMA, The Journal of the American Medical Association 2004 Michael A. Blazing | |||||
| Title | Subject | Authors | |||
|---|---|---|---|---|---|
| Early intensive vs a delayed conservative simvastatin strategy in pateints with acute coronary syndromes: Phase Z of the A to Z trial. | Health | Robert M. Califf, Harvey D. White, Eugene Braunwald, Marc A. Pfeffer, Jean-Lucien Rouleau, Michael A. Blazing, Karen E. Ramsey, James A. de Lemos, Joanne Palmisano, Keith A. A. Fox, David W. Bilheimer, Eldrin F. Lewis, Stephen D. Wiviott, Terje Pedersen, Gardner Laura H., Robin Mukherjee | |||
| Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-segment elevation acute coronary syndromes. | Health | Kenneth W. Mahaffey, Robert M. Califf, Robert A. Harrington, Elliott M. Antman, Vic Hasselblad, Eugene Braunwald, James J. Ferguson, Anatoly Langer, Shaun G. Goodman, Michael A. Blazing, James A. de Lemos, John L. Petersen, Christopher C. Nessel, Anne Le-Moigne-Amarani | |||
| Safety and efficacy of enoxaparin vs. unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin. | Health | Robert M. Califf, Harvey D. White, Vic Hasselblad, Eugene Braunwald, Peter M. DiBattiste, Steven M. Snapinn, Marc A. Pfeffer, Diego Ardissino, Michael A. Blazing, Karen E. Ramsey, James A. de Lemos, Laura H. Gardner, Joanne Palmisano, Keith A. A. Fox, David W. Bilheimer, Freek W. A. Verheugt, Eldrin F. Lewis | |||
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.